Literature DB >> 32217775

Witnessed apneas are associated with elevated tau-PET levels in cognitively unimpaired elderly.

Diego Z Carvalho1, Erik K St Louis2, Christopher G Schwarz2, Val J Lowe2, Bradley F Boeve2, Scott A Przybelski2, Ashritha Reddy2, Michelle M Mielke2, David S Knopman2, Ronald C Petersen2, Clifford R Jack2, Prashanthi Vemuri2.   

Abstract

OBJECTIVE: To assess whether informant-reported apneas during sleep (witnessed apneas) in cognitively unimpaired (CU) elderly persons are associated with higher levels of brain tau.
METHODS: From the population-based Mayo Clinic Study of Aging, we identified 292 CU elderly ≥65 years of age with both AV-1451 tau-PET and Pittsburgh compound B (PiB)-PET scans and whose bed partners and close relatives had completed a questionnaire that assessed whether participants had witnessed apneas during sleep. For this cross-sectional analysis, we selected the entorhinal and inferior temporal cortices as our regions of interest (ROIs) because they are highly susceptible to tau accumulation. PET signal was scaled to the cerebellum crus to calculate standardized uptake value ratio (SUVR). We fit linear models to assess the association between regional tau and witnessed apneas while controlling for age, sex, years of education, body mass index, hypertension, hyperlipidemia, diabetes, reduced sleep, excessive daytime sleepiness, and global PiB.
RESULTS: Forty-three participants (14.7%) were found to have witnessed apneas during sleep. The report of witnessed apneas was associated with higher tau-PET SUVR elevation in our ROIs: 0.049 SUVR (95% confidence interval [CI] 0.010-0.087, p = 0.015) in the entorhinal cortex and 0.037 SUVR (95% CI 0.006-0.067, p = 0.019) in the inferior temporal cortex after controlling for confounders.
CONCLUSION: We identified a significant association between witnessed apneas in CU elderly and elevated tau-PET signal in tau-susceptible brain regions. These results suggest a plausible mechanism that could contribute to cognitive impairment and the development of Alzheimer disease. Longitudinal observations are necessary to determine direction of causality.
© 2020 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32217775      PMCID: PMC7274847          DOI: 10.1212/WNL.0000000000009315

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  50 in total

1.  Reduced non-rapid eye movement sleep is associated with tau pathology in early Alzheimer's disease.

Authors:  Brendan P Lucey; Austin McCullough; Eric C Landsness; Cristina D Toedebusch; Jennifer S McLeland; Aiad M Zaza; Anne M Fagan; Lena McCue; Chengjie Xiong; John C Morris; Tammie L S Benzinger; David M Holtzman
Journal:  Sci Transl Med       Date:  2019-01-09       Impact factor: 17.956

2.  Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.

Authors:  Adam J Schwarz; Peng Yu; Bradley B Miller; Sergey Shcherbinin; James Dickson; Michael Navitsky; Abhinay D Joshi; Michael D Devous; Mark S Mintun
Journal:  Brain       Date:  2016-03-02       Impact factor: 13.501

Review 3.  Association of Sleep-Disordered Breathing With Cognitive Function and Risk of Cognitive Impairment: A Systematic Review and Meta-analysis.

Authors:  Yue Leng; Claire T McEvoy; Isabel E Allen; Kristine Yaffe
Journal:  JAMA Neurol       Date:  2017-10-01       Impact factor: 18.302

4.  Effects of age on sleep apnea in men: I. Prevalence and severity.

Authors:  E O Bixler; A N Vgontzas; T Ten Have; K Tyson; A Kales
Journal:  Am J Respir Crit Care Med       Date:  1998-01       Impact factor: 21.405

5.  Associations between sleep-disordered breathing, nocturnal hypoxemia, and subsequent cognitive decline in older community-dwelling men: the Osteoporotic Fractures in Men Sleep Study.

Authors:  Terri Blackwell; Kristine Yaffe; Alison Laffan; Susan Redline; Sonia Ancoli-Israel; Kristine E Ensrud; Yeonsu Song; Katie L Stone
Journal:  J Am Geriatr Soc       Date:  2015-03-02       Impact factor: 5.562

6.  Defining imaging biomarker cut points for brain aging and Alzheimer's disease.

Authors:  Clifford R Jack; Heather J Wiste; Stephen D Weigand; Terry M Therneau; Val J Lowe; David S Knopman; Jeffrey L Gunter; Matthew L Senjem; David T Jones; Kejal Kantarci; Mary M Machulda; Michelle M Mielke; Rosebud O Roberts; Prashanthi Vemuri; Denise A Reyes; Ronald C Petersen
Journal:  Alzheimers Dement       Date:  2016-09-30       Impact factor: 21.566

7.  Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle.

Authors:  Jae-Eun Kang; Miranda M Lim; Randall J Bateman; James J Lee; Liam P Smyth; John R Cirrito; Nobuhiro Fujiki; Seiji Nishino; David M Holtzman
Journal:  Science       Date:  2009-09-24       Impact factor: 47.728

Review 8.  Sleep and Alzheimer disease pathology--a bidirectional relationship.

Authors:  Yo-El S Ju; Brendan P Lucey; David M Holtzman
Journal:  Nat Rev Neurol       Date:  2013-12-24       Impact factor: 42.937

9.  Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition.

Authors:  Prashanthi Vemuri; Val J Lowe; David S Knopman; Matthew L Senjem; Bradley J Kemp; Christopher G Schwarz; Scott A Przybelski; Mary M Machulda; Ronald C Petersen; Clifford R Jack
Journal:  Alzheimers Dement (Amst)       Date:  2016-12-21

Review 10.  Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer's disease.

Authors:  Jonathan Cedernaes; Ricardo S Osorio; Andrew W Varga; Korey Kam; Helgi B Schiöth; Christian Benedict
Journal:  Sleep Med Rev       Date:  2016-02-11       Impact factor: 11.609

View more
  9 in total

1.  Dose-dependent phosphorylation of endogenous Tau by intermittent hypoxia in rat brain.

Authors:  Alexandria B Marciante; John Howard; Mia N Kelly; Juan Santiago Moreno; Latoya L Allen; Elisa J Gonzalez-Rothi; Gordon S Mitchell
Journal:  J Appl Physiol (1985)       Date:  2022-07-21

2.  Obstructive sleep apnea, cerebrovascular disease, and amyloid in older adults with Down syndrome across the Alzheimer's continuum.

Authors:  Patrick Lao; Molly E Zimmerman; Sigan L Hartley; José Gutierrez; David Keator; Kay C Igwe; Krystal K Laing; Dejania Cotton-Samuel; Mithra Sathishkumar; Fahmida Moni; Howard Andrews; Sharon Krinsky-McHale; Elizabeth Head; Joseph H Lee; Florence Lai; Michael A Yassa; H Diana Rosas; Wayne Silverman; Ira T Lott; Nicole Schupf; Adam M Brickman
Journal:  Sleep Adv       Date:  2022-05-05

Review 3.  Obstructive Sleep Apnea and Its Treatment in Aging: Effects on Alzheimer's disease Biomarkers, Cognition, Brain Structure and Neurophysiology.

Authors:  Anna E Mullins; Korey Kam; Ankit Parekh; Omonigho M Bubu; Ricardo S Osorio; Andrew W Varga
Journal:  Neurobiol Dis       Date:  2020-08-27       Impact factor: 5.996

4.  Cardiovascular Endurance Modifies the Link between Subjective Sleep Quality and Entorhinal Cortex Thickness in Younger Adults.

Authors:  Junyeon Won; Alfonso J Alfini; J Carson Smith
Journal:  Med Sci Sports Exerc       Date:  2021-10-01

Review 5.  Sleep-Based Interventions in Alzheimer's Disease: Promising Approaches from Prevention to Treatment along the Disease Trajectory.

Authors:  Susanna Cordone; Serena Scarpelli; Valentina Alfonsi; Luigi De Gennaro; Maurizio Gorgoni
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-19

6.  Sleepiness in Cognitively Unimpaired Older Adults Is Associated With CSF Biomarkers of Inflammation and Axonal Integrity.

Authors:  Diego Z Carvalho; Erik K St Louis; Scott A Przybelski; Timothy I Morgenthaler; Mary M Machulda; Bradley F Boeve; Ronald C Petersen; Clifford R Jack; Jonathan Graff-Radford; Prashanthi Vemuri; Michelle M Mielke
Journal:  Front Aging Neurosci       Date:  2022-07-11       Impact factor: 5.702

7.  Tau and β-Amyloid Burden Predict Actigraphy-Measured and Self-Reported Impairment and Misperception of Human Sleep.

Authors:  Joseph R Winer; Allison Morehouse; Laura Fenton; Theresa M Harrison; Lylian Ayangma; Mark Reed; Samika Kumar; Suzanne L Baker; William J Jagust; Matthew P Walker
Journal:  J Neurosci       Date:  2021-07-21       Impact factor: 6.167

8.  Self-reported obstructive sleep apnea, amyloid and tau burden, and Alzheimer's disease time-dependent progression.

Authors:  Omonigho M Bubu; Ogie Q Umasabor-Bubu; Arlener D Turner; Ankit Parekh; Anna E Mullins; Korey Kam; Madeline K Birckbichler; Fahad Mukhtar; Alfred K Mbah; Natasha J Williams; David M Rapoport; Mony de Leon; Girardin Jean-Louis; Indu Ayappa; Andrew W Varga; Ricardo S Osorio
Journal:  Alzheimers Dement       Date:  2020-10-08       Impact factor: 21.566

9.  Association Between Obstructive Sleep Apnea and Brain White Matter Hyperintensities in a Population-Based Cohort in Germany.

Authors:  Helena U Zacharias; Antoine Weihs; Mohamad Habes; Katharina Wittfeld; Stefan Frenzel; Tanweer Rashid; Beate Stubbe; Anne Obst; András Szentkirályi; Robin Bülow; Klaus Berger; Ingo Fietze; Thomas Penzel; Norbert Hosten; Ralf Ewert; Henry Völzke; Hans J Grabe
Journal:  JAMA Netw Open       Date:  2021-10-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.